Jeffrey E. Russel

Array ( [id] => 6997357 [patent_doc_number] => 20050137135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Novel analogues of glucose-dependent insulinotropic polypeptide' [patent_app_type] => utility [patent_app_number] => 11/042562 [patent_app_country] => US [patent_app_date] => 2005-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10674 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137135.pdf [firstpage_image] =>[orig_patent_app_number] => 11042562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199733 [patent_doc_number] => 20050164916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Glycopeptide phosphonate derivatives' [patent_app_type] => utility [patent_app_number] => 11/037934 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23141 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164916.pdf [firstpage_image] =>[orig_patent_app_number] => 11037934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6492915 [patent_doc_number] => 20100093645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'SMAC Peptidomimetics and the Uses Thereof' [patent_app_type] => utility [patent_app_number] => 10/586269 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16713 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093645.pdf [firstpage_image] =>[orig_patent_app_number] => 10586269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8283034 [patent_doc_number] => 08217137 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Fullerene-based amino acids' [patent_app_type] => utility [patent_app_number] => 10/585277 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4779 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10585277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698837 [patent_doc_number] => 20080221021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Novel Corticotropin-Releasing Factor Receptor 1 (Crfr1) Agonist' [patent_app_type] => utility [patent_app_number] => 10/586469 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12679 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221021.pdf [firstpage_image] =>[orig_patent_app_number] => 10586469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740550 [patent_doc_number] => 20080234203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Use of Substances Having Oxytocin Antagonistic Properties' [patent_app_type] => utility [patent_app_number] => 10/586260 [patent_app_country] => US [patent_app_date] => 2005-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3431 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234203.pdf [firstpage_image] =>[orig_patent_app_number] => 10586260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434934 [patent_doc_number] => 20090169520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Compounds, Pharmaceutical Compositions and Therapeutic Methods of Preventing and Treating Diseases and Disorders Associated With Amyloid Fibril Formation' [patent_app_type] => utility [patent_app_number] => 10/585695 [patent_app_country] => US [patent_app_date] => 2005-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21269 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169520.pdf [firstpage_image] =>[orig_patent_app_number] => 10585695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6996254 [patent_doc_number] => 20050136032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same' [patent_app_type] => utility [patent_app_number] => 11/031108 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 51988 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136032.pdf [firstpage_image] =>[orig_patent_app_number] => 11031108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199978 [patent_doc_number] => 20050164947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Protein kinase C peptides for use in withdrawal' [patent_app_type] => utility [patent_app_number] => 11/031428 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12936 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164947.pdf [firstpage_image] =>[orig_patent_app_number] => 11031428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 467546 [patent_doc_number] => 07235526 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Protein kinase C peptides for use in withdrawal' [patent_app_type] => utility [patent_app_number] => 11/030794 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 51 [patent_no_of_words] => 12866 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235526.pdf [firstpage_image] =>[orig_patent_app_number] => 11030794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 515570 [patent_doc_number] => 07192919 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-20 [patent_title] => 'Sustained release compositions for delivery of pharmaceutical proteins' [patent_app_type] => utility [patent_app_number] => 11/031031 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10282 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/192/07192919.pdf [firstpage_image] =>[orig_patent_app_number] => 11031031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 616447 [patent_doc_number] => 07144859 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-05 [patent_title] => 'Somatostatin agonists' [patent_app_type] => utility [patent_app_number] => 11/028785 [patent_app_country] => US [patent_app_date] => 2005-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6459 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/144/07144859.pdf [firstpage_image] =>[orig_patent_app_number] => 11028785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 386663 [patent_doc_number] => 07304032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-04 [patent_title] => 'CD-10 activated prodrug compounds' [patent_app_type] => utility [patent_app_number] => 11/022341 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 38087 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/304/07304032.pdf [firstpage_image] =>[orig_patent_app_number] => 11022341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 580973 [patent_doc_number] => 07452916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Enhancement of vascular function by modulation of endogenous nitric oxide production or activity' [patent_app_type] => utility [patent_app_number] => 11/019118 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13817 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452916.pdf [firstpage_image] =>[orig_patent_app_number] => 11019118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 899314 [patent_doc_number] => RE040119 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2008-02-26 [patent_title] => 'Adjunctive therapy' [patent_app_type] => reissue [patent_app_number] => 11/016680 [patent_app_country] => US [patent_app_date] => 2004-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1410 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/040/RE040119.pdf [firstpage_image] =>[orig_patent_app_number] => 11016680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 307111 [patent_doc_number] => 07531176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Brachyspira pilosicoli 72 kDa outer-membrane protein and diagnostic and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 10/583202 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 24851 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531176.pdf [firstpage_image] =>[orig_patent_app_number] => 10583202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265486 [patent_doc_number] => 20090118171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune' [patent_app_type] => utility [patent_app_number] => 10/582115 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18417 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118171.pdf [firstpage_image] =>[orig_patent_app_number] => 10582115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145227 [patent_doc_number] => 20050119166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Conjugates useful in the treatment of prostate cancer' [patent_app_type] => utility [patent_app_number] => 11/005075 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11573 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119166.pdf [firstpage_image] =>[orig_patent_app_number] => 11005075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063599 [patent_doc_number] => 20070225239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Pna-Neamine Conjugates and Methods for Producing and Using the Same' [patent_app_type] => utility [patent_app_number] => 10/581949 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17644 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225239.pdf [firstpage_image] =>[orig_patent_app_number] => 10581949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5820058 [patent_doc_number] => 20060024371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Biocompatible material composition adaptable to diverse therapeutic indications' [patent_app_type] => utility [patent_app_number] => 11/002837 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9147 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024371.pdf [firstpage_image] =>[orig_patent_app_number] => 11002837 [rel_patent_id] =>[rel_patent_doc_number] =>)